12:26 PM
 | 
Jun 13, 2018
 |  BC Extra  |  Financial News

AAV plasmid company StrideBio raises $15.7M series A

StrideBio Inc. (Durham, N.C.) raised $15.7 million in a series A round led by existing investor Hatteras Venture Partners with participation from new investors Takeda Ventures, UCB Ventures and Alexandria Venture Investments. StrideBio COO Richard Smith told BioCentury the...

Read the full 173 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >